CU Medical Systems, Inc. (KOSDAQ:115480)
South Korea · Delayed Price · Currency is KRW 596.00
-1.00 (-0.17%)
At close: Oct 28, 2025
CU Medical Systems Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 40,791 | 40,629 | 41,803 | 46,957 | 35,402 | 28,319 | Upgrade |
Other Revenue | - | - | -0 | -0 | - | - | Upgrade |
| 40,791 | 40,629 | 41,803 | 46,957 | 35,402 | 28,319 | Upgrade | |
Revenue Growth (YoY) | 3.74% | -2.81% | -10.98% | 32.64% | 25.01% | 1.39% | Upgrade |
Cost of Revenue | 18,001 | 19,169 | 21,479 | 22,309 | 16,980 | 15,928 | Upgrade |
Gross Profit | 22,790 | 21,460 | 20,324 | 24,648 | 18,422 | 12,391 | Upgrade |
Selling, General & Admin | 10,367 | 10,029 | 9,186 | 9,312 | 8,072 | 9,895 | Upgrade |
Research & Development | 2,587 | 2,186 | 2,912 | 2,623 | 1,845 | 1,355 | Upgrade |
Amortization of Goodwill & Intangibles | 422.63 | 422 | 414.33 | 408.03 | 892.08 | 2,018 | Upgrade |
Other Operating Expenses | 185.61 | 182.92 | 108.32 | 212.62 | 100.13 | 69.66 | Upgrade |
Operating Expenses | 15,192 | 14,106 | 15,264 | 13,366 | 16,047 | 21,261 | Upgrade |
Operating Income | 7,599 | 7,354 | 5,060 | 11,282 | 2,376 | -8,870 | Upgrade |
Interest Expense | -1,528 | -1,147 | -325.57 | -454.24 | -1,136 | -3,135 | Upgrade |
Interest & Investment Income | 353.52 | 260.31 | 89.71 | 98.72 | 162.01 | 206.28 | Upgrade |
Earnings From Equity Investments | - | - | 105.46 | - | 52.92 | - | Upgrade |
Currency Exchange Gain (Loss) | -106.71 | 685.08 | -107.07 | 311.12 | 363.39 | -263.33 | Upgrade |
Other Non Operating Income (Expenses) | -529.32 | -720.52 | 137.38 | -347.03 | -4,082 | -323.67 | Upgrade |
EBT Excluding Unusual Items | 5,788 | 6,433 | 4,960 | 10,891 | -2,264 | -12,386 | Upgrade |
Gain (Loss) on Sale of Investments | -10,461 | -9,214 | -9,637 | -1,024 | -8,046 | 636.13 | Upgrade |
Gain (Loss) on Sale of Assets | -49.88 | -42.8 | 14.42 | 861.77 | -63.41 | 412.09 | Upgrade |
Asset Writedown | - | -1,004 | -2,781 | -370.57 | -5,267 | -6,869 | Upgrade |
Other Unusual Items | 1,353 | 1,353 | - | 87.97 | 499.72 | -83.06 | Upgrade |
Pretax Income | -3,371 | -2,474 | -7,443 | 10,446 | -15,140 | -18,290 | Upgrade |
Income Tax Expense | 617.19 | 666.52 | 692.81 | 934.62 | -999.21 | 2,459 | Upgrade |
Earnings From Continuing Operations | -3,988 | -3,141 | -8,136 | 9,511 | -14,141 | -20,749 | Upgrade |
Earnings From Discontinued Operations | - | - | - | - | - | -4,832 | Upgrade |
Net Income to Company | -3,988 | -3,141 | -8,136 | 9,511 | -14,141 | -25,581 | Upgrade |
Minority Interest in Earnings | -40.92 | -63.65 | -67.68 | -85.88 | 160.15 | -158.78 | Upgrade |
Net Income | -4,029 | -3,204 | -8,204 | 9,425 | -13,981 | -25,740 | Upgrade |
Net Income to Common | -4,029 | -3,204 | -8,204 | 9,425 | -13,981 | -25,740 | Upgrade |
Shares Outstanding (Basic) | 57 | 51 | 48 | 45 | 34 | 22 | Upgrade |
Shares Outstanding (Diluted) | 57 | 51 | 48 | 45 | 34 | 22 | Upgrade |
Shares Change (YoY) | 19.29% | 7.11% | 5.90% | 33.07% | 52.90% | 36.70% | Upgrade |
EPS (Basic) | -70.18 | -62.58 | -171.59 | 208.78 | -412.11 | -1160.04 | Upgrade |
EPS (Diluted) | -71.16 | -63.00 | -172.00 | 208.78 | -412.11 | -1160.04 | Upgrade |
Free Cash Flow | 14,079 | -5,984 | 1,893 | -8,465 | -4,696 | 7,133 | Upgrade |
Free Cash Flow Per Share | 245.24 | -116.86 | 39.59 | -187.50 | -138.42 | 321.49 | Upgrade |
Gross Margin | 55.87% | 52.82% | 48.62% | 52.49% | 52.04% | 43.76% | Upgrade |
Operating Margin | 18.63% | 18.10% | 12.11% | 24.03% | 6.71% | -31.32% | Upgrade |
Profit Margin | -9.88% | -7.89% | -19.63% | 20.07% | -39.49% | -90.89% | Upgrade |
Free Cash Flow Margin | 34.52% | -14.73% | 4.53% | -18.03% | -13.26% | 25.19% | Upgrade |
EBITDA | 10,745 | 10,013 | 6,995 | 12,933 | 4,320 | -4,478 | Upgrade |
EBITDA Margin | 26.34% | 24.64% | 16.73% | 27.54% | 12.20% | -15.81% | Upgrade |
D&A For EBITDA | 3,146 | 2,658 | 1,935 | 1,651 | 1,945 | 4,392 | Upgrade |
EBIT | 7,599 | 7,354 | 5,060 | 11,282 | 2,376 | -8,870 | Upgrade |
EBIT Margin | 18.63% | 18.10% | 12.11% | 24.03% | 6.71% | -31.32% | Upgrade |
Effective Tax Rate | - | - | - | 8.95% | - | - | Upgrade |
Advertising Expenses | - | 868.01 | 817.01 | 995.38 | 194.38 | 123.9 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.